902837-17-6

Usage

Uses

Used in Pharmaceutical Industry:
3-methyl-5-(piperidin-3-yl)-1,2,4-oxadiazole is used as a central nervous system depressant for its potential anxiolytic, sedative, and anticonvulsant effects. Its psychoactive properties are also being studied for potential applications in medicinal chemistry and drug discovery.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-methyl-5-(piperidin-3-yl)-1,2,4-oxadiazole is utilized as a compound of interest for its synthesis and biological activities, which include its potential as a psychoactive substance and its effects on the central nervous system.

Upstream product

• 71962-74-8 Ethyl nipecotate 
• 148672-74-6 ethyl N-(t-butyloxycarbonyl)nipecotate 
• 1243306-92-4 tert-butyl 3-(3-methyl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate 

Downstream Products

• 1602922-99-5 (4-chlorophenyl)carbamic acid (S)-2,2,2-trifluoro-1-[3-(3-methyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-ylmethyl]-ethyl ester hydrochloride 
• 1603165-03-2 (4-chlorophenyl)carbamic acid (S)-2,2,2-trifluoro-1-[3-(3-methyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-ylmethyl]-ethyl ester 

Relevant academic research and scientific papers

COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING

The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine, receptors and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans. The compositions comprising a muscarinic agonist or a pharma.ceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.

COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING

Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.

COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING

Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.